Who
In numbers
- Trades disclosed
- 70
- Buys
- 1
- Sells
- 1
- Bought
- $51K
- Sold
- $777
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 26 Jun 2014
- Last trade
- 25 Sep 2026
- Last filed
- 29 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Sep 2026filed 29 Sep 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $45K1,569.585 at $28.67 | filing |
| 25 Sep 2026filed 29 Sep 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $45K1,569.59 at $28.67 | filing |
| 26 Jun 2026filed 30 Jun 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $45K1,852.614 at $24.29 | filing |
| 26 Jun 2026filed 30 Jun 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $45K1,852.61 at $24.29 | filing |
| 23 Apr 2026filed 27 Apr 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $205K7,686.539 at $26.67 | filing |
| 23 Apr 2026filed 27 Apr 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $205K7,686.54 at $26.67 | filing |
| 27 Mar 2026filed 30 Mar 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $45K1,664.201 at $27.04 | filing |
| 27 Mar 2026filed 30 Mar 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $45K1,664.2 at $27.04 | filing |
| 31 Dec 2025filed 5 Jan 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $45K1,807.229 at $24.90 | filing |
| 31 Dec 2025filed 5 Jan 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $45K1,807.23 at $24.90 | filing |
| 30 Sep 2025filed 2 Oct 2025 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $45K1,766.09 at $25.48 | filing |
| 30 Jun 2025filed 2 Jul 2025 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $45K1,856.44 at $24.24 | filing |
| 24 Apr 2025filed 28 Apr 2025 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $205K8,999 at $22.78 | filing |
| 31 Mar 2025filed 2 Apr 2025 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $45K1,775.85 at $25.34 | filing |
| 31 Dec 2024filed 3 Jan 2025 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $45K1,696.19 at $26.53 | filing |
| 30 Sep 2024filed 2 Oct 2024 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $45K1,554.94 at $28.94 | filing |
| 28 Jun 2024filed 1 Jul 2024 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $45K1,608.29 at $27.98 | filing |
| 25 Apr 2024filed 26 Apr 2024 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $205K8,115.6 at $25.26 | filing |
| 28 Mar 2024filed 1 Apr 2024 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $45K1,621.62 at $27.75 | filing |
| 29 Dec 2023filed 2 Jan 2024 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $45K1,563.04 at $28.79 | filing |
News
Pfizer layoffs announced at Rocky Mount, Sanford facilities in NCPFE · abc11.com · 21 Oct 2026Critical Analysis: Nexentis Technologies (NASDAQ:NXTS) versus Pfizer (NYSE:PFE)PFE · dailypolitical.com · 19 Oct 2026Pfizer's Stock Is Finally Showing Signs of Life. Could This Be the Start of a Much Bigger Rally?PFE · fool.com · 19 Oct 2026
0 headlines in the last 90 days name James C. Smith; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.